By using the Volpara website you accept our use of cookies. Here’s our privacy statement.

News

News

13 Sep 2021

Volpara Health and Riverain Technologies Sign Collaboration Agreement for Lung Cancer Screening

Read more

News

24 Aug 2021

Volpara Health Confirms Board Changes to Drive US Growth

Read more

News

29 Jul 2021

Volpara Health Receives FDA Clearance for Next-Generation Breast Density Algorithm and Architecture

Read more

News

26 Jul 2021

Volpara Adding Invitae Genetic Test Ordering to Breast Risk Software Platform

Read more

News

15 Jul 2021

Volpara Health Grows Patent Collection with Recently Granted European Protection of Image Quantification

Read more

News

6 Jul 2021

Volpara Health Announces Jill Spear as New Executive Vice President of Sales & Marketing

Read more

News

7 Apr 2021

Volpara’s latest US patent protects key features of VolparaEnterprise and VolparaLive! software

Read more

News

8 Mar 2021

Study using Volpara Health’s AI-powered image quality scoring wins Magna cum Laude award at ECR 2021

Read more

News

Volpara Health & CRA Health

1 Feb 2021

Volpara Acquires Breast Cancer Risk Assessment Company CRA Health, LLC.

Read more

News

29 Dec 2020

Volpara Health’s AI-powered Breast Density Software Central to New Breast Density Studies

Read more

Next page